PMID- 31622878 OWN - NLM STAT- MEDLINE DCOM- 20200117 LR - 20200117 IS - 1090-2414 (Electronic) IS - 0147-6513 (Linking) VI - 186 DP - 2019 Dec 30 TI - Blockage of ROS-ERK-DLP1 signaling and mitochondrial fission alleviates Cr(VI)-induced mitochondrial dysfunction in L02 hepatocytes. PG - 109749 LID - S0147-6513(19)31080-2 [pii] LID - 10.1016/j.ecoenv.2019.109749 [doi] AB - Hexavalent chromium [Cr(VI)] is a common heavy metal pollutant widely used in various industrial fields. It is well known that mitochondria are the most vulnerable targets of heavy metals, but the key molecule/event that directly mediated mitochondrial dysfunction after Cr(VI) exposure is still unclear. The present study was aimed to explore whether Cr(VI) exposure could affect the mitochondrial fission/fusion process, and whether the related abnormal mitochondrial dynamics have been implicated in Cr(VI)-induced mitochondrial dysfunction. We found that the mitochondrial dysfunction caused by Cr(VI) exposure was characterized by decreased mitochondrial respiratory chain complex (MRCC) I/II activities and levels, collapsed mitochondrial membrane potential (MMP), depleted ATP, and increased reactive oxygen species (ROS) level. Cr(VI) induced abnormal mitochondrial fission/fusion events, the antioxidant Nacetyl-L-cysteine (NAC) restored the abnormal mitochondrial function as well as the fission/fusion dynamics. ROS was the up-stream regulator of extracellular regulated protein kinases (ERK) signaling, and the application of a specific ERK1/2 inhibitor PD98059 confirmed that activation of ERK1/2 signaling was associated with the abnormal mitochondrial fission/fusion and mitochondrial dysfunction. We also demonstrated that treatment with dynamic-like protein 1 (DLP1)-siRNA rescued mitochondrial dysfunction in Cr(VI)-exposed L02 hepatocytes. We reached the conclusion that blockage of ROS-ERK-DLP1 signaling and mitochondrial fission alleviates Cr(VI)-induced mitochondrial dysfunction in L02 hepatocytes, which may provide the new avenue for developing effective strategies to protect against Cr(VI)-induced hepatotoxicity. CI - Copyright (c) 2019 Elsevier Inc. All rights reserved. FAU - Zhang, Yujing AU - Zhang Y AD - Department of Health Toxicology, Xiangya School of Public Health, Central South University, Changsha, 410078, PR China. FAU - Ma, Yu AU - Ma Y AD - Department of Health Toxicology, Xiangya School of Public Health, Central South University, Changsha, 410078, PR China. FAU - Liang, Ningjuan AU - Liang N AD - Department of Health Toxicology, Xiangya School of Public Health, Central South University, Changsha, 410078, PR China. FAU - Liang, Yuehui AU - Liang Y AD - Department of Health Toxicology, Xiangya School of Public Health, Central South University, Changsha, 410078, PR China. FAU - Lu, Chan AU - Lu C AD - Department of Health Toxicology, Xiangya School of Public Health, Central South University, Changsha, 410078, PR China. FAU - Xiao, Fang AU - Xiao F AD - Department of Health Toxicology, Xiangya School of Public Health, Central South University, Changsha, 410078, PR China. Electronic address: fangxiao@csu.edu.cn. LA - eng PT - Journal Article DEP - 20191014 PL - Netherlands TA - Ecotoxicol Environ Saf JT - Ecotoxicology and environmental safety JID - 7805381 RN - 0 (Antioxidants) RN - 0 (Carcinogens, Environmental) RN - 0 (Flavonoids) RN - 0 (Protein Kinase Inhibitors) RN - 0 (Reactive Oxygen Species) RN - 0R0008Q3JB (Chromium) RN - 18540-29-9 (chromium hexavalent ion) RN - EC 2.7.11.24 (MAPK1 protein, human) RN - EC 2.7.11.24 (MAPK3 protein, human) RN - EC 2.7.11.24 (Mitogen-Activated Protein Kinase 1) RN - EC 2.7.11.24 (Mitogen-Activated Protein Kinase 3) RN - EC 3.6.5.5 (DNM1L protein, human) RN - EC 3.6.5.5 (Dynamins) RN - SJE1IO5E3I (2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one) RN - WYQ7N0BPYC (Acetylcysteine) SB - IM MH - Acetylcysteine/pharmacology MH - Antioxidants/*pharmacology MH - Carcinogens, Environmental MH - Chromium/*toxicity MH - Dynamins/metabolism/*pharmacology MH - Flavonoids/pharmacology MH - Hepatocytes/drug effects/physiology MH - Humans MH - Liver/cytology/*drug effects/metabolism/physiopathology MH - MAP Kinase Signaling System/*drug effects MH - Membrane Potential, Mitochondrial/drug effects MH - Mitochondria/*drug effects/physiology MH - Mitochondrial Dynamics/drug effects MH - Mitogen-Activated Protein Kinase 1/metabolism MH - Mitogen-Activated Protein Kinase 3/metabolism MH - Protein Kinase Inhibitors/pharmacology MH - Reactive Oxygen Species/*metabolism MH - Signal Transduction OTO - NOTNLM OT - Dynamic-like protein 1 (DLP1) OT - Extracellular regulated protein kinases (ERK) OT - Hexavalent chromium [Cr(VI)] OT - Mitochondrial dysfunction OT - Reactive oxygen species (ROS) EDAT- 2019/10/18 06:00 MHDA- 2020/01/18 06:00 CRDT- 2019/10/18 06:00 PHST- 2019/07/05 00:00 [received] PHST- 2019/09/23 00:00 [revised] PHST- 2019/10/01 00:00 [accepted] PHST- 2019/10/18 06:00 [pubmed] PHST- 2020/01/18 06:00 [medline] PHST- 2019/10/18 06:00 [entrez] AID - S0147-6513(19)31080-2 [pii] AID - 10.1016/j.ecoenv.2019.109749 [doi] PST - ppublish SO - Ecotoxicol Environ Saf. 2019 Dec 30;186:109749. doi: 10.1016/j.ecoenv.2019.109749. Epub 2019 Oct 14.